Home » Topics » Regulatory

Regulatory
RSS

Adapalene and pharmaceutical compositions thereof for use in cancer therapy

Sep. 17, 2001

Pump therapy with insulin aspart approved by EMEA

Sep. 14, 2001

Plavix sNDA granted FDA priority review

Sep. 13, 2001

Allergan's Botox cleared in Canada for treatment of axillary hyperhidrosis

Sep. 13, 2001

FDA approves Xeloda/Taxotere combination therapy for metastatic breast cancer

Sep. 13, 2001

Further submissions announced for Visudyne

Sep. 13, 2001

Novartis, QLT seek approval for expanded use of Visudyne in E.U.

Sep. 12, 2001

Janssen seeks FDA approval of new long-acting Risperdal formulation

Sep. 10, 2001

Ortec's OrCel approved for healing donor site wounds in burn victims

Sep. 10, 2001

Pariet receives E.U. clearance for treatment of symptomatic GERD

Sep. 7, 2001

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...